FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21843911000001100: Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Feb 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
72138001000001111 Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
72138101000001112 Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 75 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) 12 tablet Has AMP True Ranitidine 75mg tablets (Cubic Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start